Q3 2025 BULLSEYE CHARTS
The Psychedelic Drug Development Pipeline
Download a PDF Copy of the Charts
Access a high-resolution PDF of the bullseye charts by entering your email. By doing so, you are also opting in to our free newsletter.
Q3 2025 Psychedelic Drug Development Bullseye Chart
By Indication Grouping
In addition to our entire pipeline Bullseye Chart, above, we have also produced a Bullseye that focuses on Phase 2+ assets, grouped by broad indication.
Download a PDF Copy of the Charts
If you would like to receive a high-resolution PDF of the bullseye charts, please enter your email below. By doing so, you are also opting in to our free newsletter.
Pα+ delivers the psychedelic drug development intelligence that serious stakeholders rely on.
Get in-depth coverage of psychedelic drug development, policy and regulation, as well as exclusive interviews and data. With expert analysis and curated insights, Pα+ keeps you informed on the decisions shaping the future of psychedelics. Subscribe today, or get in touch to discuss team plans.
Ready to subscribe to Pα+? Choose a monthly or annual plan by clicking the appropriate button below.
Looking for team/group plans? Email plus@psychedelicalpha.com.
